The CIPROFLOXACIN SOLUTION is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: CIPROFLOXACIN SUSPENSION 250MG/5ML 100ML AFTER RECONSTITUTION. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-492-8089, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | CIPROFLOXACIN SUSPENSION 250MG/5ML 100ML AFTER RECONSTITUTION |
| NSN | 6505-01-492-8089 |
| SPECIAL FEATURES | CIPROFLOXACIN MICROENCAPSULATED; 250 MG PER 5 ML, 100 ML AFTER RECONSTITUTION, ORAL SUSPENSION; THE DRUG IS COMPOSED OF TWO COMPONENTS (MICROCAPSULES AND DILUENT); STORE BELOW 25 DEGREES C (77 DEGREES F) PROTECT FROM FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CIPROFLOXACIN SUSPENSION 250MG/5ML 100ML AFTER RECONSTITUTION |